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Levofloxacin has been characterized as safe and un-
likely to cause severe adverse events. Ball et al. [1]
reported that adverse events associated with fluoroquino-
lones range from 0.5% to almost 7%. New second-genera-
tion fluoroquinolones such as levofloxacin have an ex-
tended spectrum of antimicrobial activity compared with
older substances but a similar safety profile.
The potential of fluoroquinolones to induce tendinitis
and even tendon rupture, usually of the Achilles tendon, is
low but well documented [2–7]. Although different patho-
physiological hypotheses are discussed, the mechanisms
of this effect are poorly understood. Studies performed on
rats suggest a toxic effect of fluoroquinolones on cellular
components of connective tissue structures [2]. Lesions
experimentally induced in rats by fluoroquinolone treat-
ment were characterized by edema and mononuclear cell
infiltration in the inner sheath of the Achilles tendon,
with infiltration into the adjacent synovial membrane and
joint space. Cellular pathological effects observed in the
cartilage and tendons show many identical features, indi-
cating that quinolone-induced arthropathy and tendopa-
thy are probably different clinical manifestations of the
same toxic effect on cellular components of connective
tissue structures [2]. However, the impact of additional
factors, if any, in determining susceptibility to such ad-
verse effects remains unclear.
Symptoms usually resolve within a few weeks, but in
10% of patients they may persist for several months.
Pharmacovigilance data revealed that tendinitis occurred
in 1/500,000 levofloxacin prescriptions, with tendon rup-
tures only in 1/1,6 million prescriptions [3], but there are
probably a considerable number of unidentified cases.
Tendinopathy has been most frequently reported with
perfloxacin, but also occurs with levofloxacin [4]. We
describe for the first time a patient with levofloxacin-asso-
ciated tendinitis presenting with reoccurring symptoms
induced by phenoxymethylpenicillin therapy 6 months
after stopping levofloxacin treatment.
A 65-year-old nonfebrile asymptomatic woman was
prescribed levofloxacin 500 mg/day for antibiotic treat-
ment of Yersinia-reactive arthritis in August 2001. After
day 10 of daily treatment with 500 mg levofloxacin, the
patient developed a painful inflammatory tendinopathy
of the Achilles tendon of the right leg. Levofloxacin was
stopped immediately and the symptoms resolved within 3
weeks after immobilization of the Achilles tendon.
The patient has a history of chronic bronchial asthma
and has been on oral low-dose steroids for 24 years, a
known risk factor for developing fluoroquinolone-in-
duced tendinitis. In February 2002, phenoxymethylpeni-
cillin 600,000 IE (3 tablets) a day was prescribed after
dental surgery. After taking the second dose of penicillin,
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the patient developed again tendinopathy of the Achilles
tendon of the right leg with painful induration, very simi-
lar to the clinical manifestation induced by levofloxacin.
Penicillin was discontinued and therapy was switched to
clindamycin which was given for another 4 days. The
patient’s subjective discomfort improved rapidly within
48 h after penicillin had been discontinued. After placing
the Achilles tendon at rest, the symptoms of tendinitis
completely resolved within 3 weeks.
We informed the German Federal Institute for Drugs
and Medical Devices and the Drug Commission of the
German Medical Profession. According to their database,
no other cases of levofloxacin-associated tendinitis reoc-
curring after phenoxymethylpenicillin-therapy have ever
been reported.
Age, renal dysfunction, magnesium deficiency and
long-time steroid therapy have been identified as risk fac-
tors for quinolone-associated tendinitis [5]. Therefore,
some authors even recommend avoiding fluoroquino-
lones in elderly patients, especially those receiving higher
doses of corticosteroid therapy [6]. In very rare instances,
and for unknown reasons, patients who already experi-
enced a tendinopathy after levofloxacin may be at risk of
suffering a recurrence of their tendinitis following penicil-
lin, especially if they exhibit additional risk factors. Nev-
ertheless, the mechanisms of tendinitis as a class-related
side effect of fluoroquinolones remain unclear.
This case report gives rise to the suspicion that a posi-
tive history of levofloxacin-associated tendinitis could
probably complicate any further antibiotic therapy in pre-
disposed patients. Phenoxymethylpenicillin could act as
a trigger for the reoccurrence of tendinitis. As a potential
differential diagnosis for our patient’s symptoms after
phenoxymethylpenicillin therapy we cannot completely
exclude the development of enthesitis of the right heel as a
reaction to Yersinia infection. However, this would not
explain the rapid improvement of symptoms after stop-
ping penicillin therapy and therefore seems unlikely. Dur-
ing therapy with clindamycin, no symptoms of tendinitis
reoccurred. This very special case suggests a penicillin-
induced side effect. Further research is necessary to clari-
fy the pathophysiologic mechanisms of phenoxymethyl-
penicillin.
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